ARTICLE | Company News
Cygnus other research news
December 4, 2000 8:00 AM UTC
CYGN received 2 Phase I SBIR grants totalling $200,000 from the National Institute of Diabetes and Digestive and Kidney Diseases to develop new features for GlucoWatch, which has received an approvabl...